@guerilla_pm @TeamRealityDE @quarkswdr Sorry, dachte Sie sind in der Lage Google zu bedienen. https://t.co/JOyREnNyp9
@ReinerKeller @sschyvonne @CiesekSandra @c_drosten @zeitonline @MLevitt_NP2013 Ja danke, diese Pressemeldung zu KoCo19 paßt wirklich gut zu: Es geht darum, wie (gute belastbare) Wissenschaft arbeitet und neue Erkenntnisse bringt - und wie nicht ..- https
@AndreasShrugged Thanks. It's difficult to find seroprevalence studies using representative samples, in languages other than English. Anyone have suggestions on that? Also, should I assume those were the results for the Munich protocol below? https://t.
ドイツ国内でのCOVID19のコホート研究のプロトコルが下記で紹介されています。@EUROIMMUNの抗COVID19 ELISAとELISA装置が活用されています。 #新型コロナウィルス #COVID19 #ELISA #抗体検査 https://t.co/JnwyQbLq9v
RT @EUROIMMUN: .@LMU_Uniklinikum relies on our EUROIMMUN Anti-SARS-CoV-2 ELISAs for the laboratory analyses of samples collected for their…
.@LMU_Uniklinikum relies on our EUROIMMUN Anti-SARS-CoV-2 ELISAs for the laboratory analyses of samples collected for their prospective #COVID19 cohort study Munich. Check the protocol of KoCo19 here: https://t.co/sONzV9Vqqw
@GidMK @BonellC Re: "due to the lack of a large, random sample of the population tested for antibodies" Yup. Hopefully some age-specific results out soon, tho. https://t.co/ZwgsUsLv1f https://t.co/pXKLphexi3